Literature DB >> 7119097

Clinical significance of coagulase-negative staphylococci.

C M Sewell, J E Clarridge, E J Young, R K Guthrie.   

Abstract

Although coagulase-negative staphylococci (C-NS) have been implicated in certain human infections, they are generally regarded as contaminants, and their clinical significance is questioned. To assess their role as pathogens, we studied 205 isolates of C-NS from wounds and body fluids (blood, urine, pleural and peritoneal fluids, etc.). Patient's charts were reviewed, and, by using strict criteria, a determination was made regarding the clinical significance of these isolates. The organisms were then identified to determine whether certain species of C-NS were associated with specific infections. S epidermidis sensu stricto accounted for 81% of the C-NS isolated. The frequencies of other species were: S. haemolyticus (6%), S. hominis (5%), S. capitis (4%), S. warneri (3%), and others (1%). Only two isolates were novobiocin resistant; neither was identified as S. saprophyticus. By using our criteria, 22% of the C-NS were considered to be clinically significant, and the majority of these (93%) was S. epidermidis. The most common source of the clinically relevant C-NS isolates was wounds. These data suggest that identification of C-NS species other than S. epidermidis may be of limited value in predicting clinical significance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7119097      PMCID: PMC272336          DOI: 10.1128/jcm.16.2.236-239.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Simplified scheme for routine identification of human Staphylococcus species.

Authors:  W E Kloos; K H Schleifer
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

2.  Assessment of the role of Staphylococcus epidermidis as a cause of otitis media.

Authors:  R D Feigin; P G Shackelford; J Campbell; T O Lyles; M Schechter; R D Lins
Journal:  Pediatrics       Date:  1973-10       Impact factor: 7.124

3.  The problem of infection in endoprosthetic surgery of the hip joint.

Authors:  P D Wilson; E A Salvati; P Aglietti; L J Kutner
Journal:  Clin Orthop Relat Res       Date:  1973-10       Impact factor: 4.176

4.  The McKee-Farrar total hip replacement. Preliminary results and complications of 368 operations performed in five general hospitals.

Authors:  F P Patterson; C S Brown
Journal:  J Bone Joint Surg Am       Date:  1972-03       Impact factor: 5.284

Review 5.  The narcotic addict as a medical patient.

Authors:  J D Sapira
Journal:  Am J Med       Date:  1968-10       Impact factor: 4.965

6.  Staphylococcus epidermidis (albus) endophthalmitis. Report of two cases after cataract extraction.

Authors:  M J Valenton; R F Brubaker; H F Allen
Journal:  Arch Ophthalmol       Date:  1973-02

7.  Total hip replacement with fixation by acrylic cement. A preliminary study of 100 consecutive McKee-Farrar prosthetic replacements.

Authors:  P D Wilson; H C Amstutz; A Czerniecki; E A Salvati; D G Mendes
Journal:  J Bone Joint Surg Am       Date:  1972-03       Impact factor: 5.284

8.  Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy.

Authors:  S C Schoenbaum; P Gardner; J Shillito
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

9.  Vascular prosthetic infections: collected experience and results of treatment.

Authors:  W G Liekweg; L J Greenfield
Journal:  Surgery       Date:  1977-03       Impact factor: 3.982

10.  Continuous ambulatory peritoneal dialysis.

Authors:  R P Popovich; J W Moncrief; K D Nolph; A J Ghods; Z J Twardowski; W K Pyle
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

View more
  41 in total

1.  Rapid and accurate identification of coagulase-negative staphylococci by real-time PCR.

Authors:  K J Edwards; M E Kaufmann; N A Saunders
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Reproducibility of API Staph-Ident system identifications of coagulase-negative staphylococci isolated from blood.

Authors:  T L Overman; J K Overley
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

3.  Species-level identification of staphylococcal isolates by real-time PCR and melt curve analysis.

Authors:  Aine Skow; Kathy A Mangold; Mohammed Tajuddin; Anne Huntington; Brett Fritz; Richard B Thomson; Karen L Kaul
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Clinical significance of coagulase-negative staphylococci recovered from nonsterile sites.

Authors:  Thean Yen Tan; Siew Yong Ng; Wan Xing Ng
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  Identification of Staphylococcus species directly from positive blood culture broth by use of molecular and conventional methods.

Authors:  Maitry S Mehta; Suzanne M Paule; Richard B Thomson; Karen L Kaul; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

Review 6.  Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis.

Authors:  J T Parisi
Journal:  Microbiol Rev       Date:  1985-06

7.  Antibiotic prophylaxis in cardiothoracic surgery in the United Kingdom: current practice.

Authors:  A P Wilson; T Treasure; M F Sturridge; R N Grüneberg
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

8.  Evaluation of Staf-Sistem 18-R for identification of staphylococcal clinical isolates to the species level.

Authors:  R Piccolomini; G Catamo; C Picciani; D D'Antonio
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Septicemia due to coagulase-negative Staphylococcus in a community hospital.

Authors:  J Righter
Journal:  CMAJ       Date:  1987-07-15       Impact factor: 8.262

10.  Identification of Staphylococcus species of bovine origin with the API Staph-Ident system.

Authors:  B E Langlois; R J Harmon; K Akers
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.